サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1179898

義肢・人工関節の世界市場-2023-2030

Global Artificial Limbs and Joints Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
義肢・人工関節の世界市場-2023-2030
出版日: 2023年01月05日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

義肢は、外傷や先天性欠損症によって失われた身体の一部を補うものです。義肢の種類は、手足の欠損や切断の理由、欠損した四肢の部位など、個人によって異なります。

市場力学

世界の義肢・人工関節市場は、技術の進歩、義肢・人工関節の採用拡大、患者の意識向上、美容整形への支出増などによって牽引されています。

手足が不自由な人の人口が増加し、市場の成長を牽引

患者の意識向上による義肢・人工関節の需要増が予測期間の市場を牽引します。人間の四肢、特に上肢と手の複雑さにより、私たちは世界と交流することができます。義肢技術、外科的イノベーション、リハビリテーションの強化における最近の進歩は、損傷前の機能レベルに戻ることを望む四肢欠損の患者にとって有望なようです。

2022年のProsthesis誌に掲載された記事によると、世界には4000万人以上の四肢欠損者がおり、そのほとんどがいかなる形の補装具治療も受けられないでいます。世界保健機関は、上肢（UL）の欠損がこの人口の約16％を占めると推定しています。ULの遺伝的な差異に関する世界の推定値は大きく異なり、4～5/10,000～1/100生誕の範囲です。後天性四肢切断は、様々な病因によるものがありますが、主な原因は外傷であることが多いです。

その他の特典として、静音性、信頼性の向上、訓練期間の短縮、メンテナンスの簡略化、軽量化、適度なコスト、固有感覚フィードバック、ユーザーの体動を利用して端末装置を任意に開閉する簡単な操作機構などが報告されています。また、任意に閉じるBPプロテーゼは、ユーザーに拡張された生理学的なプロプリオセプティクスを提供します。ユーザーが関わる可能性のある道具に固有感覚を拡張するのです。

義肢・人工関節に関連する問題が市場の成長を阻害する

しかし、患者が利用できるほとんどのUL義肢は、手頃な価格でもなく、より厳しい環境でも適用できないことがよくあります。適切な義肢の問題は、選択肢が少ないため、子供や青年にとってはさらに切実な問題です。これらの要因が市場の成長を妨げています。

COVID-19の影響分析

COVID-19の登場は、世界の義肢・人工関節市場に大きな影響を与えました。2020年にThe Journal of Arthroplastyに掲載された記事によると、COVID-19の大流行により、大流行の影響を抑えるために例外的な規制が行われ、社会のあらゆる側面に影響を及ぼしました。ヘルスケア業界は特に影響を受けています。ACS、CMS、およびほとんどの州は、COVID-19の流行中は必須の外科的処置のみを行うよう勧告または要求しています。

しかし、このように不要な外科手術の削減が義務付けられると、ヘルスケアシステムに大きな影響を与えることになります。さらに、米国では人工股関節置換術と人工膝関節置換術が手術件数のかなりの割合を占めていることから、これらの政策が人工股関節置換術の患者さんや、患者さんをケアする医療機関・医療関係者にとって厳しいものであることは間違いありません。

しかし、キャンセルされた症例の再手術が急増すると予測されるのは、世界的に義肢・人工関節の需要が高まっていることから、患者が手術の再手術を希望したり、新規患者が手術の適応を希望する状況が回復しつつあるためと思われます。

目次

第1章 市場調査手法と範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 老年人口の増加
      • 交通事故や職場での事故の増加
    • 抑制要因
      • 規制ガイドラインの観点からの参入障壁
    • ビジネスチャンス
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 規制分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 製品タイプ別

  • 人工関節
  • 義肢

第8章 技術別

  • 装飾義肢
  • 有線/バッテリー式義肢
  • 電動/筋電義肢

第9章 アプリケーション別

  • 人工膝
  • 人工骨盤
  • 人工肘
  • 人工肩
  • 人工腕
  • 人工脚

第10章 エンドユーザー別

  • 病院
  • ASC
  • リハビリテーションセンター
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第12章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • タイプ別ベンチマーク

第13章 企業プロファイル

  • Arthrex Inc
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Depuy Synthes（Johnson & Johnson）（Johnson & Johnson）
  • Djo Surgical
  • Integra Lifesciences
  • Smith & Nephew
  • Stryker Corporation
  • Wright Medical Group
  • Zimmer Holdings Inc.
  • Ossur
  • Conmed Corporation

第14章 義肢・人工関節の世界市場-DataM

目次
Product Code: DMMD1647

Market Overview

The global artificial limbs and joints market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period (2023-2030).

Artificial limbs, or prostheses, substitute a missing body part lost due to trauma or congenital deficiency. The type of prosthesis a person can use depends on the individual, including the reason for limb loss or amputation and the location of the missing extremity.

Market Dynamics

The global artificial limbs and the joint market is driven by technological advancements, the growing adoption of artificial limbs and joints, improving patient awareness, and rising expenditure on cosmetic procedures.

The increasing population of limb-deficient individuals drives the market growth

The rising demand for artificial limbs and joints due to increasing patient awareness drives the market in the forecast period. The complexity of the human extremity, particularly the upper extremity and the hand, allows us to interact with the world. Recent advances in prosthesis technology, surgical innovations, and enhanced rehabilitation appear promising for patients with limb loss who hope to return to their pre-injury level of function.

As per the article published in Prosthesis in 2022, There are over 40 million limb-deficient individuals worldwide, most of whom do not have access to any form of prosthetic care. The World Health Organization has estimated that upper-limb (UL) loss or absence accounts for about 16% of this population. Global estimates for genetic UL differences vary widely and range from 4 to 5/10,000 to 1/100 live births. Acquired UL amputations can be due to a wide variety of aetiologies, with the primary cause often being trauma.

In addition, the reported benefits of body-powered (BP) prostheses include silent action, increased reliability, reduced training period, simple maintenance, lightweight, moderate cost, proprioceptive feedback, and a simple operational mechanism that uses the body motions of the user to voluntary open or close the terminal device. Also, a voluntary closing BP prosthesis offers the user extended physiological proprioception. It extends the proprioceptive feedback to tools that users might engage with.

The issues associated with artificial limbs and joints will hamper the growth of the market

However, most UL prosthetics available to patients are often neither affordable nor applicable in more challenging environments. The issue of appropriate prosthetics is even more pressing for children and adolescents, as fewer options are available. These factors are hampering the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global artificial limbs and joints market. As per the article published in The Journal of Arthroplasty in 2020, the COVID-19 pandemic has resulted in exceptional restrictions to curb the pandemic's impact, impacting all aspects of society. The healthcare industry has been particularly affected. The ACS, the CMS, and most states have advised or required that only essential surgical procedures be performed during the COVID-19 outbreak.

However, this mandated reduction of unnecessary surgical procedures will profoundly impact the healthcare system. Furthermore, given that hip and knee arthroplasty comprise a substantial share of the surgical volume in the U.S., there is no doubt these policies are hard felt by hip and knee arthroplasty patients and the providers and institutions that care for them.

However, a predicted surge of rescheduling canceled cases is based on the assumption that patients will want to reschedule their surgery or new patients will want to be indicated for surgery, as the situation is recovering from COVID-19-results in the increasing demand for artificial limbs and joints worldwide.

Segment Analysis

The artificial knee segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The artificial knee segment accounts for the largest market share. As per the article published in the Journal of clinical medicine 2021, total knee arthroplasty (TKA) is a very effective treatment for severe osteoarthritis. TKA leads to good results in returning to daily activities, good survival rates, and overall functional improvement. Technologies such as navigation, smart tools, patient-specific instrumentation (PSI), and computer or robotic-assisted surgery (CAS) aim to individualize the surgery and account for the anatomy and ligament balancing of each patient to improve the accuracy of the surgical planning in three dimensions (3D), to increase alignment accuracy and reliability, and improve implant positioning.

In addition, the key players are adopting market strategies such as product launches and collaboration to expand their business. For instance, in April 2022, Researchers at the Indian Institute of Technology-Madras (IIT-M) introduced India's first polycentric prosthetic knee. Named 'Kadam,' the indigenously designed prosthetic knee aims to enhance the quality of life of above-knee amputees.

Geographical Analysis

North America region holds the largest market share of the global artificial limbs and joints market

North America dominates the artificial limbs and joints market and is anticipated to show a parallel trend over the forecast period. The market is boosted by factors such as advanced healthcare infrastructure, the increasing incidence of injuries and accidents, active regional key players, and growing awareness about advanced prosthetic technologies in the North American region.

As per the article published in Current Reviews in Musculoskeletal Medicine in 2020, an estimated 1.6 million Americans were living with limb loss in 2005, with a projected increase to 3.6 million by 2050. Upper extremity limb loss accounts for approximately one-third of that group, though major amputations (those proximal to the digits) represent only 8% of upper extremity amputations. Trauma is the second main cause of amputation, occurring at approximately one-eighth of the amputation rate secondary to vascular disease.

As per the article published in Techniques in Orthopaedics in December 2021, presently, 2.1 million people in the U.S. live with limb loss, with 185,000 amputations happening each year. Amputation numbers are predicted to rise with increasing age, diabetes, and vascular disease in the population. Advances in surgical techniques and prosthetic technology have created the potential for amputees to live active and productive lives.

Competitive Landscape

The artificial limbs and joints market is a moderately competitive presence of local and global companies. Some key players contributing to the market's growth are Arthrex Inc, Depuy Synthes (Johnson & Johnson) (Johnson & Johnson), Djo Surgical, Integra Lifesciences, Smith & Nephew, Stryker Corporation, Wright Medical Group, Zimmer Holdings Inc., Ossur, and Conmed Corporation, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the artificial limbs and joints market globally.

For instance,

  • In September 2021, the Cleveland Clinic-led international research team developed the bionic system that combines three important functions - intuitive motor control, touch and grip kinesthesia, and the intuitive feeling of opening and closing the hand. Collaborators included the University of Alberta and the University of New Brunswick.

Allergan plc

Overview:

Stryker Corporation is a medical device company founded in 1941 and headquartered in the United States. The company offers innovative products and services in neurotechnology, medical and surgical, orthopaedics and spine that help enhance patient and hospital outcomes.

Product Portfolio:

Accolade II: The company created Accolade II's Morphometric Wedge to manage modern demands with novel technology by developing a conventional tapered wedge femoral stem design with size-specific medial curvature to more closely fit an expansive range of bone sizes and shapes of today's patient population.

The global artificial limbs and joints market report would provide access to approximately 65+ market data tables, 60+ figures, and in the range of 200+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Number of Geriatric Population
      • 4.1.1.2. Increasing Number of Road Mishaps and Work Place Incidents
    • 4.1.2. Restraints:
      • 4.1.2.1. Entry Barriers in Terms of Regulatory Guidelines
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Artificial Joints*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Artificial Limbs

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Cosmetic Prosthetics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Cable-operated/Battery-powered Prosthetics
  • 8.4. Electrically-powered/Myoelectric Prosthetics

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Artificial Knee*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Artificial Hip
  • 9.4. Artificial Elbow
  • 9.5. Artificial Shoulder
  • 9.6. Artificial Arm
  • 9.7. Artificial Leg

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. ASCs
  • 10.4. Rehabilitation Centers
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Type Benchmarking

13. Company Profiles

  • 13.1. Arthrex Inc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Depuy Synthes (Johnson & Johnson) (Johnson & Johnson)
  • 13.3. Djo Surgical
  • 13.4. Integra Lifesciences
  • 13.5. Smith & Nephew
  • 13.6. Stryker Corporation
  • 13.7. Wright Medical Group
  • 13.8. Zimmer Holdings Inc.
  • 13.9. Ossur
  • 13.10. Conmed Corporation

LIST NOT EXHAUSTIVE

14. Global Artificial Limbs and Joints Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us